Skip to main content

Table 5 Interaction between the studied polymorphisms and smoking status.

From: Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes

 

Smoking

IRRA95% CI

p-valueB

 

Never

Past

Current

Smoking

 
 

NC

NS

NC

NS

NC

NS

Never

Past

Current

 

NFkB -94ins/del

             

   II

37

101

37

101

47

105

1.00

-

0.89

(0.51-1.55)

1.15

(0.67-1.97)

0.84

   ID and DD

79

149

76

137

102

163

1.45

(0.89-2.37)

1.41

(0.86-2.33)

1.55

(0.96-2.51)

 

PXR rs1523127

             

   AA

33

94

42

76

52

87

1.00

-

1.37

(0.77-2.47)

1.55

(0.89-2.70)

0.08

   AC and CC

83

156

71

162

97

181

1.49

(0.90-2.45)

1.15

(0.69-1.91)

1.38

(0.84-2.28)

 

PXR rs2276707

             

   CC

63

141

70

135

104

165

1.00

-

1.01

(0.65-1.57)

1.24

(0.82-1.87)

0.43

   CT and TT

53

109

43

103

45

103

1.06

(0.66-1.68)

0.89

(0.54-1.47)

0.93

(0.57-1.51)

 

PXR rs6785049

             

   AA

40

89

38

85

58

85

1.00

-

0.92

(0.52-1.61)

1.37

(0.80-2.33)

0.28

   AG and GG

76

161

75

153

91

183

1.06

(0.65-1.72)

1.00

(0.61-1.63)

1.04

(0.64-1.67)

 

LXR rs1405655

             

   CC

49

117

54

116

66

114

1.00

-

0.93

(0.56-1.54)

1.18

(0.72-1.92)

0.83

   CT and TT

67

133

59

122

83

154

1.07

(0.66-1.72)

1.01

(0.62-1.64)

1.11

(0.71-1.74)

 

LXR rs2695121

             

   TT

36

74

35

63

46

84

1.00

-

1.12

(0.61-2.07)

1.20

(0.67-2.13)

0.67

   CT and CC

80

176

78

175

103

184

0.98

(0.59-1.63)

0.85

(0.51-1.42)

1.03

(0.63-1.70)

 
  1. AAdjusted for age, sex, status of hormone replacement therapy (HRT)(women only), alcohol, dietary fibre and BMI, physical activity and NSAID use.
  2. B P-value for interaction.